Screening and identification of human nasopharyngeal carcinoma-associated antigens

Journal of Sichuan University (Medical Science)

Volumn 36, Issue 6, 2005, Pages 800-803

  Cui, Xiao Bo ^a   Xie, Ke ^a   Liang, Chuan Yu ^a   Deng, Hong Xin ^a   Wei, Yu Quan ^a   Tian, Ling ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

cDNA expression library; Nasopharyngeal carcinoma; SEREX; Tumor antigen

Indexed keywords

BETA 2 MICROGLOBULIN; BIOCHEMICAL MARKER; COMPLEMENTARY DNA; MELANOMA ANTIGEN 1; RIBOSOME PROTEIN; TUMOR ANTIGEN;

ARTICLE; CANCER SCREENING; COMPUTER PROGRAM; CONTROLLED STUDY; DNA DETERMINATION; DNA LIBRARY; GENE EXPRESSION; HUMAN; IMMUNOPATHOLOGY; MOLECULAR CLONING; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; SEROLOGY;

EID: 28944445912     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ahin U, Tureci O, Schmitt H, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA, 1995;95(25):11810.
2. Li B, Qian XP, Pang XW. et al. HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma. Lab Invest, 2003;83(8):1185.
3. Koroleva EP, Lagarkova MA, Mesheryakov AA, et al. Serological identification of antigens associated with renal cell carcinoma. Russ J Immunol, 2002;7(3):229.
4. Stockert E, Jager E, Chen YT, et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med, 1998;187(4):1349.
5. Wei YQ, Wang QR, Zhao X, et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med, 2000;6(10):1160.
6. Coulie PG, Karanikas V, Lurquin C, et al. Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen. Immunological Reviews, 2002;188(6):33.
7. Sybren L, Walter J, Hong-Ming Hu, et al. Adoptive cell therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/β-2-microglobulin gene-modified autologous tumor cells. Journal of Immunotherapy, 2002;25(4):359.
8. Manfred T, Dusan M, Madeleine P, et al. Expression of the extra domain B of fibronectin, a marker of angiogenesis in Head and Neck tumors. The Laryngoscope. 2003;113(2):1231.